Muutke küpsiste eelistusi

E-raamat: Dietary Interventions in Gastrointestinal Diseases: Foods, Nutrients, and Dietary Supplements

Edited by (Professor, Mel and Enid Zuckerman College of Public Health and School of Medicine, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA), Edited by (Professor, Department of Clinical Biochemistry, Kings College Hospital, London)
  • Formaat: EPUB+DRM
  • Ilmumisaeg: 10-Jan-2019
  • Kirjastus: Academic Press Inc
  • Keel: eng
  • ISBN-13: 9780128144695
  • Formaat - EPUB+DRM
  • Hind: 184,28 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: EPUB+DRM
  • Ilmumisaeg: 10-Jan-2019
  • Kirjastus: Academic Press Inc
  • Keel: eng
  • ISBN-13: 9780128144695

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Dietary Interventions in Gastrointestinal Diseases: Foods, Nutrients and Dietary Supplements provides valuable insights into the agents that affect metabolism and other health-related conditions in the gastrointestinal system. It provides nutritional treatment options for those suffering from gastrointestinal diseases including Crohn’s Disease, Inflammatory Bowel Disease, Ulcerative Colitis and Allergies, among others. Information is presented on a variety of foods, including herbs, fruits, soy and olive oil, thus showing that changes in intake can change antioxidant and disease preventing non-nutrients and affect gastrointestinal health and/or disease promotion.

This book serves as a valuable resource for biomedical researchers who focus on identifying the causes of gastrointestinal diseases and food scientists targeting health-related product development.

  • Provides information on agents that affect metabolism and other health-related conditions in the gastrointestinal tract
  • Explores the impact of composition, including differences based on country of origin and processing techniques to highlight compositional differences and their effect on the gastrointestinal tract
  • Addresses the most positive results from dietary interventions using bioactive foods to impact gastrointestinal diseases, including reduction of inflammation and improved function of organs
List of Contributors
xiii
Biography xvii
Acknowledgments xix
Section I Background and Overview of Diet and GI Tract Health
1 Plant Family, Carvacrol, and Putative Protection in Gastric Cancer
Ayse Gunes Bayir
Huriye Senay Kiziltan
Abdurrahim Kocyigit
1 Plant Family and Phytochemicals
3(1)
1.1 General Properties of Dietary Phytochemicals
3(1)
1.2 Classification of Phytochemicals
3(1)
1.3 Mechanisms of Phytochemicals in Cancer Chemoprevention
3(1)
2 Carvacrol
4(5)
2.1 Carvacrol as a Molecule
4(1)
2.2 Carvacrol Sources
4(1)
2.3 Chemical and Physical Properties of Carvacrol
5(1)
2.4 Metabolism and Excretion of Carvacrol
5(1)
2.5 Acute Toxicity of Carvacrol
5(1)
2.6 Biological Activities of Carvacrol
5(4)
3 Dietary Phytochemicals in Gastric Cancer Chemoprevention
9(1)
4 Gastric Cancer
10(9)
4.1 Anatomy and Physiology
10(1)
4.2 Epidemiology of Gastric Cancer
10(1)
4.3 Etiology of Gastric Cancer
10(1)
4.4 Pathology of Gastric Cancer
11(1)
4.5 Types of Gastric Cancer
11(1)
4.6 Stages of Gastric Cancer
12(1)
4.7 Clinical Symptoms
13(1)
4.8 Diagnosis of Gastric Cancer
13(1)
4.9 Treatments
13(1)
References
14(5)
2 The Physics of Fiber in the Gastrointestinal Tract: Laxation, Antidiarrheal, and Irritable Bowel Syndrome
Johnson W. McRorie Jr.
1 Introduction
19(1)
2 Chronic Idiopathic Constipation
20(4)
2.1 Most Fibers Have No Laxative Effect, and at Least Four Can Be Constipating
20(1)
2.2 Insoluble Fiber/Wheat Bran and Laxation
20(1)
2.3 Soluble Gel-Forming Fiber/Psyllium and Laxation
21(1)
2.4 Misconceptions About Fiber and Laxation
21(1)
2.5 Summary: Fiber and Laxation
22(2)
3 Antidiarrheal Effects of Fiber
24(2)
3.1 Fermented Fibers/Prebiotics and Treatment/Prevention of Diarrhea
24(1)
3.2 Prebiotics: Traveler's Diarrhea, Antibiotic-Associated Diarrhea, and Clostridium difficile-Associated Diarrhea
24(1)
3.3 Fermented Fibers/Prebiotics and Enteral Nutrition-Induced Diarrhea
24(1)
3.4 Mixed Fibers and Enteral Nutrition-Induced Diarrhea
25(1)
3.5 Gel-Forming Fibers and Treatment/Prevention of Diarrhea
25(1)
4 Fiber and Irritable Bowel Syndrome
26(2)
4.1 Fermentable Fiber/Prebiotics and Irritable Bowel Syndrome
26(1)
4.2 Insoluble Wheat Bran and Irritable Bowel Syndrome
26(1)
4.3 Guar Gum and Irritable Bowel Syndrome
27(1)
4.4 Calcium Polycarbophil and Irritable Bowel Syndrome
27(1)
4.5 Psyllium and Irritable Bowel Syndrome
27(1)
4.6 Summary: Fiber and Irritable Bowel Syndrome
28(1)
4.7 Recommendation to Begin Fiber Therapy Gradually
28(1)
5 Overall Conclusions for Fiber and Laxation, Antidiarrheal, and Irritable Bowel Syndrome
28(5)
References
28(5)
3 Dietary Interventions and Inflammatory Bowel Disease
Zeinab Mokhtari
Azita Hekmatdoost
1 Introduction
33(1)
1.1 Clinical Manifestations and Complications of Inflammatory Bowel Disease
33(1)
2 Nutritional Issues/Common Problems in Inflammatory Bowel Disease
34(1)
2.1 Vitamin D Deficiency in Inflammatory Bowel Disease
34(1)
2.2 Anemia in Inflammatory Bowel Disease
34(1)
3 Nutritional Assessment
35(1)
4 Nutritional Interventions in Inflammatory Bowel Disease
35(1)
5 Some Popular Dietary Intervention in Inflammatory Bowel Disease
35(3)
5.1 Enteral Nutrition in Inflammatory Bowel Disease
35(2)
5.2 Dietary Recommendations in Practice
37(1)
6 Conclusions
38(5)
References
38(5)
4 The Gastrointestinal System and Obesity
Gerardo Calderon
Andres Acosta
1 Introduction
43(1)
1.1 Obesity: Definition, Epidemiology, and Pathophysiology
43(1)
2 Gastrointestinal Regulation of Food Intake
43(6)
2.1 The Gastrointestinal Tract in Regulation of Food Intake and Regulation of Energy Balance
45(4)
3 Complication of Obesity in Gastrointestinal Tract
49(5)
3.1 Oral Disease
49(2)
3.2 Esophagus
51(1)
3.3 Stomach
51(1)
3.4 Small Intestine
52(1)
3.5 Colon
53(1)
3.6 Anorectal
54(1)
3.7 Pancreas
54(1)
3.8 Liver Disease
54(1)
4 Treatment of Obesity Focused in the Gastrointestinal Tract
54(3)
4.1 Diets
55(1)
4.2 Drugs
55(1)
4.3 Bariatric Procedures
56(1)
5 Conclusions
57(6)
Disclosures
57(1)
References
57(6)
5 Constipation: A Symptom of Chronic Food Intolerance?
I. Kearsey
Y.I. Yik
B.R. Southwell
J.M. Hutson
1 Introduction
63(1)
2 Chronic Constipation
63(2)
2.1 Definition
63(1)
2.2 Epidemiology
63(1)
2.3 Etiology
64(1)
2.4 Clinical Assessment
64(1)
2.5 Current Management Practices
64(1)
3 Emerging Views of Pediatric Chronic Constipation
65(3)
3.1 The Nuclear Colonic Transit Study
65(2)
3.2 Colonic Dysmotility Subtypes
67(1)
3.3 Slow-Transit Constipation
67(1)
3.4 Rapid-Transit Constipation
68(1)
4 Adverse Food Reactions and Chronic Constipation
68(3)
4.1 Adverse Food Reactions
68(1)
4.2 Adverse Food Reactions (AFR's) and Chronic Constipation
69(1)
4.3 Exclusion Diet as a Management Strategy for Chronic Constipation
70(1)
5 Conclusion
71(2)
References
71(2)
6 Food, Nutrients, and Dietary Supplements in Management of Disorders of Gut-Brain Interaction, Formerly Functional Gastrointestinal Disorders
Amol Sharma
Jigar Bhagatwala
1 Introduction
73(1)
2 Reflux Hypersensitivity and Functional Heartburn
74(1)
3 Functional Dyspepsia
75(1)
4 Irritable Bowel Syndrome and Functional Constipation
76(2)
5 Summary
78(3)
References
79(2)
7 Vitamin D and Quality of Life of Patients With Irritable Bowel Syndrome
Amir Abbasnezhad
Razieh Choghakhori
1 Introduction
81(1)
2 Health-Related Quality of Life of Irritable Bowel Syndrome Patients
81(2)
3 Functions of Vitamin D
83(1)
4 Vitamin D Deficiency in Irritable Bowel Syndrome
83(1)
5 Vitamin D and Quality of Life in Irritable Bowel Syndrome
83(2)
6 Discussion
85(1)
7 Conclusions 86 List of Abbreviations 86 References
86(5)
Section II Nutrition and GI Tract
8 Sealing the Leaky Gut Represents a Beneficial Mechanism of Zinc Intervention for Alcoholic Liver Disease
Wei Zhong
Zhanxiang Zhou
1 Introduction
91(1)
2 Gut Barrier Dysfunction in the Development of Alcoholic Liver Disease
92(2)
2.1 Alcohol-Induced Cut Hyperpermeability
92(1)
2.2 Bacterial Translocation and Hepatic Signaling in Alcoholic Liver Disease
93(1)
3 Zinc Metabolism and Function
94(1)
3.1 Physiological Functions of Zinc
94(1)
3.2 Regulation of Zinc Homeostasis
94(1)
4 Zinc Deficiency in Alcoholic Liver Disease
95(3)
4.1 Occurrence of Zinc Deficiency in Alcoholic Liver Disease
95(1)
4.2 Mechanisms of Alcohol-Induced Zinc Deficiency
96(1)
4.3 Effects of Zinc Deficiency on the Liver
97(1)
4.4 Effects of Zinc Deficiency on the Gut Barrier
97(1)
5 Zinc Intervention for Alcoholic Liver Disease
98(2)
5.1 Dietary Zinc Supplementation Prevents Alcohol-Induced Endotoxemia and Intestinal Barrier Dysfunction
99(1)
5.2 Dietary Zinc Supplementation Restores the Function of Intestinal HNF-4α
100(1)
5.3 Dietary Zinc Supplementation Reduces Endotoxin Levels in the Intestinal Lumen
100(1)
6 Conclusion
100(7)
References
101(6)
9 Exclusive Enteral Nutrition in Children With Crohn's Disease: A Focused Nutritional Intervention
Andrew S. Day
1 Introduction
107(1)
2 Crohn's Disease
107(1)
3 Nutritional Impact of Chron's Disease in Children
108(1)
4 Exclusive Enteral Nutrition
109(2)
4.1 Typical Exclusive Enteral Nutrition Protocol
109(1)
4.2 Exclusive Enteral Nutrition and Induction of Remission
109(1)
4.3 Other Benefits of Exclusive Enteral Nutrition
109(1)
4.4 Adverse Effects of Exclusive Enteral Nutrition
110(1)
4.5 EEN for Complicated CD
110(1)
4.6 Maintenance EN to Maintain Remission/Prevent Relapse
110(1)
5 Mechanisms of Action of Exclusive Enteral Nutrition
111(1)
5.1 Putative Mechanisms of Action of Exclusive Enteral Nutrition
111(1)
5.2 Exclusive Enteral Nutrition and the Intestinal Microbiota
111(1)
5.3 EEN Has Direct Antiinflammatory Effects and Enhances Barrier Function in Epithelial Cells
111(1)
6 Conclusions
112(5)
References
113(4)
10 Gut Microbes in Liver Diseases: Dietary Intervention for Promoting Hepatic Health
Aryashree Arunima
Jugal Kishore Das
Mrutyunjay Suar
1 Introduction
117(1)
2 Gut Microbiota
117(2)
2.1 Gut Homeostasis
118(1)
2.2 Gut Dysbiosis
118(1)
3 Gut Microbiota and Liver
119(2)
3.1 Liver as Vascular Sentinel of the Immune System
119(1)
3.2 Gut-Liver Axis
120(1)
3.3 Factors Affecting the Gut Microbiota in Liver Disease
120(1)
4 Liver Diseases and Role of Gut Microbiota
121(2)
4.1 Nonalcoholic Fatty Liver Disease
121(1)
4.2 Alcoholic Fatty Liver Disease
122(1)
4.3 Hepatic Fibrogenesis
122(1)
4.4 Hepatic Encephalopathy
122(1)
4.5 Viral Hepatitis
122(1)
4.6 Hepatocellular Carcinoma
123(1)
4.7 Liver Cirrhosis
123(1)
4.8 Inflammatory Bowel Diseases
123(1)
5 Dietary Intervention Strategies for Liver Diseases
123(3)
5.1 Probiotic Therapy
124(1)
5.2 Probiotic-Based Intervention for Promoting Hepatic Health
124(1)
5.3 Prebiotics
125(1)
6 Future Prospects
126(9)
List of Abbreviations
126(9)
Acknowledgments
127(1)
References
127(8)
Section III Probiotics, Prebiotics, Symbiotics in Intestinal Functions
11 Feasible Options to Control Colonization of Enteric Pathogens With Designed Synbiotics
Mengfei Peng
Puja Patel
Vinod Nagarajan
Cassandra Bernhardt
Michael Carrion
Debabrata Biswas
1 Introduction
135(1)
2 Probiotics and Its Role in the Prevention of Enteric Pathogen Colonization
136(2)
2.1 Environment of the Gut Flora
136(1)
2.2 Interaction Between Probiotics and Intestinal Epithelial Barrier
137(1)
2.3 Strengthening of the Epithelial Barrier
138(1)
2.4 Application of Probiotics in Prevention of Enteric Bacterial Infections
138(1)
3 Probiotics and Its Antimicrobial Role in Reduction of Enteric Bacterial Pathogen Growth
138(2)
3.1 Probiotics Producing Antimicrobial Substances
139(1)
3.2 Antimicrobial Action by Probiotics
139(1)
3.3 Antimicrobial Activity of Probiotics in Food Products
140(1)
4 Combined Effect of Pre- and Probiotic and Its Limitation
140(3)
4.1 The Combined Effects in Form of Synbiotics
141(1)
4.2 Mechanisms of Synbiotics in Preventing Enteric Diseases
141(1)
4.3 The Double Inhibitory Actions by Synbiotics
142(1)
4.4 Limitations of Synbiotics Application
142(1)
5 Feasible Alternative to Overcome the Limitation of Symbiotic
143(1)
5.1 Alternative Functional Ingredients to Probiotics
143(1)
5.2 Limitation in Prebiotics and Potential Solutions
144(1)
5.3 Antimicrobials' Potential in Combinational Alternatives
144(1)
6 Conclusion
144(7)
Acknowledgments
145(1)
References
145(6)
12 The Role of Prebiotics in Disease Prevention and Health Promotion
Rabin Gyawali
Nwadiuto Nwamaioha
Rita Fiagbor
Tahi Zimmerman
Robert H. Newman
Salam A. Ibrahim
1 Concept of Prebiotics
151(1)
2 Modulation of Gut Microbiota
152(1)
3 Prebiotics Effects in Human Health
153(5)
3.1 Production of Short-Chain Fatty Acids
153(1)
3.2 Colon Cancer
154(1)
3.3 Inflammatory Bowel Disease
155(1)
3.4 Cardiovascular Disease
156(1)
3.5 Type II Diabetes and Glycemic Control
157(1)
3.6 Weight Management
157(1)
3.7 Immune Function
158(1)
4 Synbiotic Approach
158(3)
5 Insight Into Prebiotics Effect on the Growth of Harmful Bacteria
161(2)
6 Conclusions and Future Directions
163(6)
Acknowledgments
163(1)
References
163(6)
13 Probiotics From Food Products and Gastrointestinal Health
Murat Dogan
Ismail Hakki Tekiner
Hilal Demirkesen Bicak
1 Introduction
169(1)
2 Probiotic Concept
169(1)
3 Mechanisms of Action of Probiotics
170(1)
3.1 Antimicrobial Effects
170(1)
3.2 Enhancement of Mucosal Barrier Integrity
171(1)
3.3 Immune Modulation
171(1)
4 Dietary Interventions of Probiotics in Gastrointestinal Disorders
171(1)
5 Probiotic Functional Foods, Status, and Claims
172(1)
6 Conclusions
173(6)
List of Abbreviations
173(1)
References
174(5)
14 Prebiotics for Gastrointestinal Infections and Acute Diarrhea
Ignasi Azagra-Boronat
Maria Jose Rodriguez-Lagunas
Margarida Castell
Francisco J. Perez-Cano
1 Introduction
179(1)
2 Gastrointestinal Infections
179(2)
3 Prebiotics: Types and Mechanisms of Action
181(2)
3.1 Definition and Types of Prebiotics
181(1)
3.2 Mechanisms of Action in the Protection of Gastrointestinal Infections
181(1)
3.3 Microbiota-Dependent Mechanisms
181(2)
3.4 Microbiota-Independent Mechanisms
183(1)
4 Prebiotics in Gastrointestinal Diseases
183(4)
4.1 In Vitro Evidences
183(1)
4.2 Evidences in Animal Models of Infection
183(3)
4.3 Prebiotics in Human Infections of the Gastrointestinal Tract
186(1)
5 Conclusions
187(6)
List of Abbreviations
187(1)
References
188(5)
15 Probiotics and Applications to Constipation
Elena Scarpato
Vincenzo Coppola
Annamaria Staiano
1 The Role of Microbiota in Gut Motility
193(1)
2 Gut Microbiota and Gastrointestinal Health
193(1)
3 Microbiota Alterations in Functional Constipation
194(1)
4 Probiotics in the Management of Functional Constipation
194(1)
5 Conclusions
195(2)
References
195(2)
16 New Functional Properties of Fermented Rice Bran in Food Processing and Inflammatory Bowel Disease Model Mice
Takashi Kuda
1 Introduction
197(1)
2 Preparation of Fermented Rice Bran for Ammonia Reduction in Shark Meat
198(1)
3 Effect of Fermented Rice Bran on Ammonia Content and Preference Ranking in Shark and Other Fish Meat
199(1)
4 Dietary and Lifestyle Disease Indices and Cecal Microbiota in High-Fat Diet, Dietary Fiber-Free Diet, or DSS-Induced IBD Models in Closed Colony Mice
199(1)
5 Protective Effects of FRB in DSS-Induced IBD Model ICR Mice
200(4)
5.1 Total Phenolic Content and Antioxidant Properties
201(1)
5.2 Immune Promotion and Antiinflammation Activity in Murine Macrophage RAW264.7 Cells
201(2)
5.3 Protective Effects of FRB-AES in DSS-Induced IBD Model ICR Mice
203(1)
6 Conclusion
204(5)
Acknowledgments
204(1)
References
204(2)
Further Reading
206(3)
Section IV Microbes and GI Tract
17 Zataria multiflora and Gastrointestinal Tract Disorders
T. Shomali
1 Introduction
209(1)
2 Beneficial Effects of ZM on Different Gastrointestinal Tract Diseases
210(3)
2.1 Stomatitis and Intraoral Ulcers
210(1)
2.2 Gastric or Duodenal Ulcers
210(1)
2.3 Irritable Bowel Syndrome and Inflammatory Bowel Disease
210(1)
2.4 Intestinal Infections
211(1)
2.5 Colon Cancer Chemopreventive Effect
211(1)
2.6 Hepatoprotective Effects
211(1)
2.7 Road Mapping for Future Studies and Conclusion
211(1)
References
212(1)
18 Influence of a Cocoa-Enriched Diet on the Intestinal Immune System and Microbiota
Mariona Camps-Bossacoma
Malen Massot-Cladera
Francisco J. Perez-Cano
Margarida Castell
1 Introduction
213(1)
2 Cocoa Composition
213(1)
3 Cocoa and Gut Microbiota
214(3)
3.1 Role of Cocoa Flavonoids on Cocoa Microbiota Influence
215(1)
3.2 Cocoa Fiber and Microbiota
216(1)
3.3 Cocoa Theobromine and Microbiota
216(1)
4 Cocoa and the Intestinal Immune System
217(2)
4.1 Cocoa and the Intestinal Epithelium
217(1)
4.2 Cocoa and the Intestinal immunoglobulin A
217(1)
4.3 Cocoa and Gut-Associated Lymphoid Tissue Populations
218(1)
5 Cocoa in Gastrointestinal Disease and Food Hypersensitivity
219(2)
5.1 Influence of Cocoa intake in Intestinal Inflammation
219(1)
5.2 Food Allergy
220(1)
6 Conclusions
221(8)
List of Abbreviations
222(7)
References
222(7)
Section V Foods and Macro Dietary Materials in GI Function
19 High-Fiber Diets in Gastrointestinal Tract Diseases
Ana Leticia Malheiros Silveira
Adaliene Versiani Matos Ferreira
Mauro Martins Teixeira
1 Basic Concepts: Dietary Fiber
229(1)
2 Gastrointestinal Tract and Microbiota Interaction
230(1)
3 Stomach and Gastritis
231(1)
3.1 High-Fiber Diet in Gastritis
231(1)
4 Inflammatory Bowel Disease
232(6)
4.1 Microbiota and Inflammatory Bowel Disease
232(1)
4.2 Dietary Fiber in Inflammatory Bowel Disease
233(5)
5 Mucositis
238(1)
5.1 Microbiota and Mucositis
239(1)
5.2 Dietary Fiber in Mucositis
239(1)
6 Conclusion
239(6)
References
240(5)
20 Dietary Interventions in Fatty Liver
Zahra Yari
Azita Hekmatdoost
1 Introduction
245(1)
2 Soy
245(1)
3 Egg
246(1)
4 Nuts
246(1)
5 Probiotics, Prebiotics, and Synbiotics
246(1)
6 Seal Oil (N-3 Polyunsaturated Fatty Acids)
247(1)
7 Flaxseed
248(1)
8 Curcumin
248(1)
9 Resveratrol
248(1)
10 Pomegranate
249(1)
11 Onion
249(1)
12 Conclusion
250(7)
References
250(7)
21 Rice Bran Usage in Diarrhea
Shaohua Lei
Lijuan Yuan
1 Overall Health Benefits of Rice Bran Dietary Supplement
257(1)
2 Dietary Rice Bran Supplementation in Reducing Diarrhea
257(2)
2.1 Diarrhea in Irritable Bowel Syndrome
257(1)
2.2 Human Rotavirus-Induced Diarrhea
258(1)
2.3 Human Noroviruses-Induced Diarrhea
259(1)
3 Mechanisms for Rice Bran Usage in Reducing Diarrhea
259(2)
3.1 Antimicrobial and Antiviral Activities
260(1)
3.2 Prebiotic and Microbiota Modulatory Properties
260(1)
3.3 Effects on Intestinal Immunity and Overall Health
260(1)
4 Future Perspective
261(4)
References
261(4)
22 Milk Bacteria and Gastrointestinal Tract: Microbial Composition of Milk
Aseel T. Issa
Reza Tahergorabi
1 Introduction
265(1)
2 Sources of Milk Organisms
265(1)
3 Contamination in the Mammary Glands
265(1)
4 Contamination Sources in the External Environment
265(1)
5 Contamination From Handling and Storage Equipment
266(1)
6 Microbial Composition of Milk From Different Sources
266(2)
6.1 Cow Milk
266(1)
6.2 Goat Milk
267(1)
6.3 Sheep Milk
267(1)
6.4 Buffalo Milk
267(1)
6.5 Other Types of Milk
267(1)
7 Important Microorganisms Found in Raw Milk
268(2)
7.1 Lactococcus
268(1)
7.2 Bifidobacterium
269(1)
7.3 Lactobacillus
269(1)
7.4 Streptococcus
269(1)
7.5 Propionibacterium
269(1)
7.6 Leuconostoc
269(1)
7.7 Enterococcus
269(1)
7.8 Gram-Positive Subpopulations
270(1)
7.9 Gram-Negative Subpopulations
270(1)
7.10 Fungal Populations
270(1)
7.11 Psychrotrophic
270(1)
8 Impact of Storage Conditions and Treatments
270(2)
8.1 Cold Storage
270(1)
8.2 Pasteurization
271(1)
8.3 Bacteriophage
271(1)
9 Biopreservative Potential of Raw Milk Microorganisms
272(1)
10 Human Health Association
272(1)
11 Pathogenic Bacteria Found in Milk
272(1)
11.1 Listeria monocytogenes
272(1)
11.2 Staphylococcus aureus
272(1)
11.3 Escherichia coli
272(1)
11.4 Salmonella
273(1)
11.5 Coxiella burnetii
273(1)
11.6 Mycobacterium bovis
273(1)
11.7 Brucella
273(1)
11.8 Filamentous fungi
273(1)
12 Health-Promoting Bacteria
273(1)
13 Conclusion
273(4)
Acknowledgments
274(1)
References
274(3)
23 Polyphenols in the Prevention of Ulcerative Colitis: A Revisit
Elroy Saldanha
Arpit Saxena
Kamaljit Kaur
Faizan Kalekhan
Ponemone Venkatesh
Raja Fayad
Suresh Rao
Thomas George
Manjeshwar Shrinath Baliga
1 Introduction
277(1)
2 Curcumin, the Active Component of Turmeric
277(1)
3 Resveratrol
278(1)
4 Quercetin
279(1)
5 Kaempferol
279(1)
6 Ellagic Acid
279(1)
7 Rutoside or Rutin
280(1)
8 Green Tea Polyphenols in Colitis
280(2)
9 Grape Seed Polyphenols
282(1)
10 Silymarin
282(1)
11 Polyphenols of Apple
282(2)
12 Cocoa
284(1)
13 Conclusions
284(1)
List of Abbreviations 284(1)
References 285(4)
Index 289
Ronald Ross Watson, PhD, is Professor of Health Promotion Sciences at the University of Arizona, Mel and Enid Zuckerman College of Public Health. Dr. Watson began his research in public health at the Harvard School of Public Health as a Fellow in 1971 doing field work on vaccines in Saudi Arabia. He has done clinical studies in Colombia, Iran, Egypt, Saudi Arabia and the United States which provides a broad international view of public health. He has served in the military reserve hospital for 17 years with extensive training in medical responses to disasters as the chief biochemistry officer of a general hospital, retiring as a Lt. Colonel. He is a distinguished member of several national and international nutrition, immunology, and cancer societies. Dr. Watsons career has involved studying many lifestyle aspects for their uses in health promotion. He has edited over 100 biomedical reference books and 450 papers and chapters. His teaching and research focuses on alcohol, tobacco, and drugs of abuse in heart function and disease in mouse models. Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at Kings College Hospital and Emeritus Professor of Nutritional Biochemistry at Kings College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at Kings College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books.